ChemBioChem · 2018 · 19 citations · 25 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyVaccinologyAntigen DesignCancer ImmunotherapyCancer VaccinesImmunotherapy For Breast CancerTumor-associated AntigensVaccine Antigen DesignAberrant Glycosylation In CancerImmunogenicity Of Tumor AntigensMucin AntigensSynthetic VaccineTetanus Toxoid VaccineTumor Antigen ImmunogenicityTumor-associated Antigen VaccinesTumor-associated Carbohydrate Antigens
The endothelial glycoprotein MUC1 is known to underlie alterations in cancer by means of aberrant glycosylation accompanied by changes in morphology. The heavily shortened glycans induce a collapse of the peptide backbone and enable accessibility of the latter to immune cells, rendering it a tumor-associated antigen. Synthetic vaccines based on MUC1 tandem repeat motifs, comprising tumor-associated 2,3-sialyl-T antigen, conjugated to the immunostimulating tetanus toxoid, are reported herein. Immunization with these vaccines in a simple water/oil emulsion produced a strong immune response in mice to which stimulation with complete Freund's adjuvant (CFA) was not superior. In both cases, high levels of IgG1 and IgG2a/b were induced in C57BL/6 mice. Additional glycosylation in the immunodominant PDTRP domain led to improved binding of the induced antisera to MCF-7 breast tumor cells, compared with that of the monoglycosylated peptide vaccine.
25
Frederick P. Heinzel, M D Sadick, B J Holaday et al. · The Journal of Experimental Medicine · 1989 · 1.5K citations · Full text
T and Tn, General Carcinoma Autoantigens
Georg F. Springer · Science · 1984 · 1K citations
Life Sciences, Immunology, Oncology +17
Robert Sewell, Malin Bäckström, Martin Dalziel et al. · Journal of Biological Chemistry · 2005 · 255 citations · Full text